EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H14N4O2 |
| Net Charge | 0 |
| Average Mass | 330.347 |
| Monoisotopic Mass | 330.11168 |
| SMILES | N#CCC[C@@H]1NC(=O)c2ccccc2-n2c1nc1ccccc1c2=O |
| InChI | InChI=1S/C19H14N4O2/c20-11-5-9-15-17-21-14-8-3-1-6-12(14)19(25)23(17)16-10-4-2-7-13(16)18(24)22-15/h1-4,6-8,10,15H,5,9H2,(H,22,24)/t15-/m0/s1 |
| InChIKey | JJFMDWQPUDJAHC-HNNXBMFYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (-)-auranthine (CHEBI:747452) is a benzodiazepine (CHEBI:22720) |
| (-)-auranthine (CHEBI:747452) is a organic heterotetracyclic compound (CHEBI:38163) |
| UniProt Name | Source |
|---|---|
| (-)-auranthine | UniProt |
| Citations |
|---|